Aptorum (APM)
Aptorum Group Limited, through its subsidiaries, a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of the...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.7000
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 4.4700
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- PUBT · 1 day ago, 08:32 PM
Aptorum names Ian Huen CEO in post-merger management change
- PUBT · Aug 21 at 09:18 PM
Aptorum files amended 8-K updating DiamiR Biosciences financial statements
- businessinsider · Aug 21 at 09:16 PM
Aptorum Group GAAP EPS of -$1.60
- PUBT · Aug 21 at 09:07 PM
Aptorum FY26 H1 net loss widens to $1.31 million; operating cash outflow rises to $1.55 million
- TradingView · Jul 24 at 08:36 PM
Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% Stake
